Company: IXHL
Filing Date: 2025-04-17
Form Type: PRER14A
Source: 0001213900-25-033013
Chunk: 25

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-17
Form: PRER14A
Chunk 25
---
) to the greater of (I) the Floor Price (as defined below) and (II) the lowest daily dollar-volume-weighted-average-price during
the period beginning two full trading days prior to the Release Date and ending on the 10 trading day after the Release Date.
Upon any such resulting adjustment of the exercise price in the Series A Warrants, the number of Series A Warrant Shares issuable under
the Series A Warrants will be increased such that the aggregate exercise price of a Series A Warrants (adjusted for any exercises by a
holder prior to this adjustment) will remain unchanged following such adjustment. No adjustment in connection with a Release Date or otherwise
may result in an adjustment of the exercise price to a price less than the Floor Price. As a result, the aggregate number of shares of
common stock underlying all of the Series A Warrants, may increase from 11,574,090 to up to 115,740,900, assuming full adjustment of the
exercise price to the Floor Price and before giving effect to the zero exercise price provision. Assuming full adjustment of the exercise
price to the Floor Price, the aggregate number of shares of common stock issuable upon the exercise of all of the Series A Warrants pursuant
to the zero exercise price provisions therein would be 347,222,700.

: If,
for any reason, less than all of the securities sold pursuant to the Purchase Agreements have been registered for resale prior to the
expiration of the 90-day period immediately following the trading day during which the Company files a Current Report on Form 8-K giving
public notice of the approval of the Warrant Stockholder Approval, then a Series A Warrant holder, with respect to itself only, will have
the right in its sole and absolute discretion, to deem that the Release Date has occurred with respect to such portion of a Series A Warrant
as the holder determines and an Adjustment Date shall apply to that portion of the Series A Warrant. Any portion of a Series A Warrant
not previously subject to an adjustment as a result of an exercise by the Holder in accordance with the previous sentence, will remain
subject to a future adjustment in in connection with a Release Date. No partial adjustment may result in an adjustment of the exercise
price to a price less than the Floor Price.

<div align='center'>13</div>

: If at any time during the term of the Series A Warrants there occurs any share split, reverse share
split, share dividend, share